In January 2016, the Institute for Behavior and Health, Inc. (IBH) released a report calling for a sustained and systematic annual collection, analysis and reporting of data related to the public health, safety and other consequences of marijuana use and marijuana legalization.
Over the last year IBH has explored opportunities for national leadership on this vital initiative. As a result of that exploration, IBH has revised its Strategy calling on US Congress to designate the National Academy of Sciences, Engineering and Medicine (NASEM) to establish an independent Scientific Committee to Monitor the Effects of Marijuana Policy Changes.
As described in the revision of "A Strategy to Assess the Consequences of Marijuana Legalization", there is ample precedence for Congress to take on this role.
The charge of the Scientific Committee would include:
To assemble, synthesize and interpret available data and research pertaining to the effects of marijuana use and the effects of...
Kratom, a plant-based drug with opioid-like effects, is an emerging public health threat, the Centers for Disease Control and Prevention (CDC) warns.
In a new report, the CDC says the number of kratom-related calls to poison control centers in 2015 was 10 times higher than in 2010, according to MedPage Today.
Last year, poison control centers received 263 such calls. Kratom is often taken in combination with other drugs, such as ethanol, botanicals, benzodiazepines, narcotics, and acetaminophen.
Kratom can lead to psychosis, seizures and death, the CDC said. It is on the Drug Enforcement Administration’s Drugs of Concern list, but is unregulated at the federal level.